Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Nature Genetics

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ng.491PMID 19946270PMCID PMC4002225
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ubiquitin‐mediated control of oncogene and tumor suppressor gene products

  2009cited by this paper
• High-Resolution Genomic Copy Number Profiling of Glioblastoma Multiforme by Single Nucleotide Polymorphism DNA Microarray

  2009cited by this paper
• Molecular interaction between parkin and PINK1 in mammalian neuronal cells.

  2009cited by this paper
• Functional Copy-Number Alterations in Cancer

  2008cited by this paper
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways

  2008cited by this paper
• Parkin mediates the degradation‐independent ubiquitination of Hsp70

  2008cited by this paper
• Aggregopathy in Neurodegenerative Diseases: Mechanisms and Therapeutic Implication

  2008cited by this paper
• Array-Comparative Genomic Hybridization Analysis of Primary Endometrial and Ovarian High-grade Neuroendocrine Carcinoma Associated With Adenocarcinoma: Mystery Resolved?

  2008cited by this paper
• An Integrated Genomic Analysis of Human Glioblastoma Multiforme

  2008cited by this paper
• Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.

  2008cited by this paper
• Parkin protects against tyrosinase‐mediated dopamine neurotoxicity by suppressing stress‐activated protein kinase pathways

  2008cited by this paper
• Parkin Regulates Eg5 Expression by Hsp70 Ubiquitination-dependent Inactivation of c-Jun NH2-terminal Kinase*

  2008cited by this paper
• Both SCF(Cdc4alpha) and SCF(Cdc4gamma) are required for cyclin E turnover in cell lines that do not overexpress cyclin E.

  2008cited by this paper
• Both SCFCdc4α and SCFCdc4γ are required for cyclin E turnover in cell lines that don’t overexpress cyclin E

  2008cited by this paper
• Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease

  2007cited by this paper
• Characterizing the cancer genome in lung adenocarcinoma

  2007cited by this paper
• PolyScan: an automatic indel and SNP detection approach to the analysis of human resequencing data.

  2007cited by this paper
• Cyclin E overexpression impairs progression through mitosis by inhibiting APCCdh1

  2007cited by this paper
• Genomic mutation consequence calculator

  2007cited by this paper
• Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.

  2006cited by this paper
• Ubiquitin-proteasome system and Parkinson's diseases.

  2005cited by this paper
• Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.

  2005cited by this paper
• Parkin interacts with the proteasome subunit α4

  2005cited by this paper
• Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.

  2005cited by this paper
• A survey of homozygous deletions in human cancer genomes.

  2005cited by this paper
• Parkinson's disease: from causes to mechanisms.

  2005cited by this paper
• Parkin interacts with the proteasome subunit alpha4.

  2005cited by this paper
• Parkinson's disease: assays for the ubiquitin ligase activity of neural Parkin.

  2005cited by this paper
• Mutation of hCDC4 Leads to Cell Cycle Deregulation of Cyclin E in Cancer

  2004cited by this paper
• Parkin gene alterations in hepatocellular carcinoma

  2004cited by this paper
• Inactivation of hCDC4 can cause chromosomal instability

  2004cited by this paper
• Parkinson's disease

  2004cited by this paper
• Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene

  2004cited by this paper
• Atypical cancer pattern in patients with Parkinson's disease

  2004cited by this paper
• Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity.

  2003cited by this paper
• The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.

  2003cited by this paper
• Alterations in the common fragile site gene Parkin in ovarian and other cancers

  2003cited by this paper
• Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25–q27

  2003cited by this paper
• PTEN: One Gene, Many Syndromes

  2003cited by this paper
• Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin‐like domain

  2003cited by this paper
• Astrocytic but not neuronal increased expression and redistribution of parkin during unfolded protein stress

  2002cited by this paper
• CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity.

  2002cited by this paper
• Identification of molecular determinants required for interaction of ubiquitin-conjugating enzymes and RING finger proteins.

  2001cited by this paper
• E3 ubiquitin-protein ligase activity of Parkin is dependent on cooperative interaction of RING finger (TRIAD) elements.

  2001cited by this paper
• Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease

  2001cited by this paper
• Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line

  2001cited by this paper
• Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

  2000cited by this paper
• Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1.

  2000cited by this paper
• Molecular cloning, gene expression, and identification of a splicing variant of the mouse parkin gene

  2000cited by this paper
• Association between early-onset Parkinson's disease and mutations in the parkin gene.

  2000cited by this paper
• Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity*

  2000cited by this paper
• Cyclin E in human cancers

  1999cited by this paper
• Deregulated cyclin E induces chromosome instability

  1999cited by this paper
• A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.

  1999cited by this paper
• Consed: a graphical tool for sequence finishing.

  1998cited by this paper
• Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

  1998cited by this paper
• PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing.

  1997cited by this paper
• Ataxia-telangiectasia and the ATM gene: Linking neurodegeneration, immunodeficiency, and cancer to cell cycle checkpoints

  1996cited by this paper
• Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors

  1996cited by this paper
• The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.

  1996cited by this paper
• The FHIT Gene at 3p14.2 Is Abnormal in Lung Cancer

  1996cited by this paper
• Occurrence of different cancers in patients with Parkinson's disease

  1995cited by this paper
• Ageing and Parkinson's disease: substantia nigra regional selectivity.

  1991cited by this paper

• Mitophagy in the pathogenesis and management of disease

  2026cites this paper
• Mitophagy and Ubiquitination Coordinate Context-Specific Mitochondrial Quality Control and EMT/MET Plasticity to Drive Cancer Cell Invasion.

  2026cites this paper
• De novo identification of potent ingredients for proteasome activation in MT101-5 using an AI-driven approach.

  2026cites this paper
• The anti-tumour role of ketogenic diet based on energy metabolism.

  2025cites this paper
• Genetically encoded and modular subcellular organelle probes reveal dysfunction in lysosomes and mitochondria driven by PRKN knockout

  2025cites this paper
• Mitophagy: A double-edged sword in tumor cell death regulation and therapeutic response.

  2025cites this paper
• Genetic predispositions and nutritional strategies: a review of nutrigenomics in Parkinson's disease.

  2025cites this paper
• Mitochondrial Dysfunction in Aging, HIV, and Long COVID: Mechanisms and Therapeutic Opportunities

  2025cites this paper
• Effects of Parkinson’s disease on survival in cancer survivors: a retrospective, multicentre cohort study in Japan

  2025cites this paper
• Parkinson's Disease and Cancer: Mechanistic Insights and Therapeutic Opportunities From Cancer Neuroscience

  2025cites this paper
• Beyond the brain: The colorectal impact of Parkinson's disease

  2025cites this paper
• NIPSNAP1 and NIPSNAP2 facilitate healthy aging independent of mitophagy.

  2025cites this paper
• Mitophagy’s impacts on cancer and neurodegenerative diseases: implications for future therapies

  2025cites this paper
• Mitochondrial Quality Control in Neurodegeneration and Cancer: A Common Denominator, Distinct Therapeutic Challenges

  2025cites this paper
• Nanotechnology-Targeted Modulation of Mitophagy in Cancer Therapy: Progress and Challenges.

  2025cites this paper
• Parkin, a key player in Parkinson's disease pathogenesis: A review.

  2025cites this paper
• Synapsin III promotes neuronal-like transdifferentiation of glioblastoma stem cells by disrupting JAG1-Notch1 interaction.

  2025cites this paper
• High penetrance rare variants underlying familial lung cancer risk: Insights from genetic epidemiology of lung cancer consortium.

  2025cites this paper
• The interconnective role of the UPS and autophagy in the quality control of cancer mitochondria

  2025cites this paper
• Engineering a cell-based orthogonal ubiquitin transfer cascade for profiling the substrates of RBR E3 Parkin

  2025cites this paper
• α-synuclein expression in glioblastoma restores tumor suppressor function and rescues temozolomide drug resistance

  2025cites this paper
• Evaluating the Antitumor Potential of Cannabichromene, Cannabigerol, and Related Compounds from Cannabis sativa and Piper nigrum Against Malignant Glioma: An In Silico to In Vitro Approach

  2025cites this paper
• Autophagy Reprogramming in Cancer

  2025cites this paper
• The interplay between mitochondrial dynamics and autophagy: From a key homeostatic mechanism to a driver of pathology.

  2024cites this paper
• Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives

  2024cites this paper
• Parkin inhibits proliferation and migration of bladder cancer via ubiquitinating Catalase

  2024cites this paper
• Mutant p53 reactivation restricts the protumorigenic consequences of wild type p53 loss of heterozygosity in Li-Fraumeni syndrome patient-derived fibroblasts

  2024cites this paper
• Association between Parkinson’s Disease and Cancer: New Findings and Possible Mediators

  2024cites this paper
• Targeting the Metabolic Paradigms in Cancer and Diabetes

  2024cites this paper
• Pan-cancer molecular signatures connecting aspartate transaminase (AST) to cancer prognosis, metabolic and immune signatures

  2024cites this paper
• Suppression of Glioblastoma Stem Cell Potency and Tumor Growth via LRRK2 Inhibition

  2024cites this paper
• Chronic replication stress invokes mitochondria dysfunction via impaired parkin activity

  2024cites this paper
• Genetically Encoded and Modular SubCellular Organelle Probes (GEM-SCOPe) reveal lysosomal and mitochondrial dysfunction driven by PRKN knockout

  2024cites this paper
• The prognostic role of mitophagy marker Parkin-induced protein kinase 1 in invasive duct carcinoma of the breast: an immunohistochemical study

  2024cites this paper
• Comparative Analysis of the Immunohistochemical Expression of the Parkin and APC proteins in Polyps and Colorectal Adenocarcinomas

  2024cites this paper
• Iron chelators as mitophagy agents: Potential and limitations.

  2024cites this paper
• MANF facilitates breast cancer cell survival under glucose-starvation conditions via PRKN-mediated mitophagy regulation

  2024cites this paper
• Parkin deficiency promotes liver cancer metastasis by TMEFF1 transcription activation via TGF-β/Smad2/3 pathway

  2024cites this paper
• Discovery of potent LRRK2 inhibitors by ensemble virtual screening strategy and bioactivity evaluation.

  2024cites this paper
• Biological and therapeutic implications of the cancer-related germline mutation landscape in lung cancer.

  2024cites this paper
• CIBRA identifies genomic alterations with a system-wide impact on tumor biology

  2024cites this paper
• Deficiency in the mitophagy mediator Parkin accelerates murine skin allograft rejection.

  2024cites this paper
• Role of Autophagy and AMPK in Cancer Stem Cells: Therapeutic Opportunities and Obstacles in Cancer

  2024cites this paper
• A comprehensive review on signaling attributes of serine and serine metabolism in health and disease.

  2024cites this paper
• The multifaceted role of quaking protein in neuropsychiatric disorders and tumor progression

  2024cites this paper
• Unravelling the genetic links between Parkinson’s disease and lung cancer

  2023cites this paper
• Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation.

  2023cites this paper
• Replication stress in mammalian embryo development, differentiation, and reprogramming.

  2023cites this paper
• Comprehensive molecular characterization of adenoid cystic carcinoma reveals tumor suppressors as novel drivers and prognostic biomarkers

  2023cites this paper
• Chemotherapy-induced neuronal DNA damage: an intriguing toolbox to elucidate DNA repair mechanisms in the brain

  2023cites this paper
• Natural compounds modulating mitophagy: Implications for cancer therapy.

  2023cites this paper
• Deubiquitinases in cancer

  2023cites this paper
• Gene signals and SNPs associated with Parkinson's disease: A nutrigenomics and computational prospective insights.

  2023cites this paper
• The iron chelator and OXPHOS inhibitor VLX600 induces mitophagy and an autophagy-dependent type of cell death in glioblastoma cells.

  2023cites this paper
• MitoQ combats tumor cell progression in Ehrlich ascites carcinoma mice: A crosstalk between mitochondrial oxidative status, mitophagy, and NF-κB signaling.

  2023cites this paper
• Tumor suppressor Parkin induces p53-mediated cell cycle arrest in human lung and colorectal cancer cells

  2023cites this paper
• FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2‐Mediated Alternative Splicing

  2023cites this paper
• The mitophagy pathway and its implications in human diseases

  2023cites this paper
• Application of codon usage and context analysis in genes up- or down-regulated in neurodegeneration and cancer to combat comorbidities

  2023cites this paper
• Sporadic pituitary adenoma with somatic double-hit loss of MEN1

  2023cites this paper
• Low expression of PINK1 and PARK2 predicts poor prognosis in patients with esophageal squamous cell carcinoma

  2023cites this paper
• Longitudinal study of the inverse relationship between Parkinson’s disease and cancer in Korea

  2023cites this paper
• A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma

  2022cites this paper
• The oncoprotein MUC1 facilitates breast cancer progression by promoting Pink1-dependent mitophagy via ATAD3A destabilization

  2022cites this paper
• Characterization of immune features and immunotherapy response in subtypes of hepatocellular carcinoma based on mitophagy

  2022cites this paper
• Stress-induced reversible cell-cycle arrest requires PRC2/PRC1-mediated control of mitophagy in Drosophila germline stem cells and human iPSCs

  2022cites this paper
• The Roles of ATP13A2 Gene Mutations Leading to Abnormal Aggregation of α-Synuclein in Parkinson’s Disease

  2022cites this paper
• Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study

  2022cites this paper
• The relationship between Parkinson’s disease and gastrointestinal diseases

  2022cites this paper
• Quaking but not parkin is the major tumor suppressor in 6q deleted region in glioblastoma

  2022cites this paper
• Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas

  2022cites this paper
• Performing Single-Cell Clonal Analysis in the Mouse Brain Using Mosaic Analysis with Double Markers (MADM).

  2022cites this paper
• Autophagy regulation by RNA alternative splicing and implications in human diseases

  2022cites this paper
• Association of Parkin with P53 expression and their prognostic significance in north Indian colorectal cancer patients

  2022cites this paper
• Pink1 promotes cell proliferation and affects glycolysis in breast cancer

  2022cites this paper
• The RING finger protein family in health and disease

  2022cites this paper
• Mitophagy and oral cancers

  2022cites this paper
• Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes

  2022cites this paper
• Therapeutic potential of parkin as a tumor suppressor via transcriptional control of cyclins in glioblastoma cell and animal models

  2021influential citation
• Aging, mitochondria, and autophagy

  2021cites this paper
• Cancer risk in Parkinson disease: An updated systematic review and meta‐analysis

  2021cites this paper
• A cancer ubiquitome landscape identifies metabolic reprogramming as target of Parkin tumor suppression

  2021cites this paper
• Failure to Guard: Mitochondrial Protein Quality Control in Cancer

  2021cites this paper
• The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside

  2021cites this paper
• Mitophagy in aging and longevity

  2021cites this paper
• Biomarkers in Parkinson s Disease - An Effective Tool for Diagnosis of PD

  2021cites this paper
• Antimony exposure promotes bladder tumor cell growth by inhibiting PINK1-Parkin-mediated mitophagy.

  2021cites this paper
• Parkin: A targetable linchpin in human malignancies.

  2021cites this paper
• Stem cell quiescence requires PRC2/PRC1-mediated mitochondrial checkpoint

  2021cites this paper
• Exome Sequencing in BRCA1-2 Candidate Familias: The Contribution of Other Cancer Susceptibility Genes

  2021cites this paper
• Role of Polyphenols on Gut Microbiota and the Ubiquitin-Proteasome System in Neurodegenerative Diseases.

  2021cites this paper
• Mitophagy in tumorigenesis and metastasis

  2021cites this paper
• Molecular analysis of cyclin D1 modulators PRKN and FBX4 as candidate tumor suppressors in sporadic parathyroid adenomas

  2021cites this paper
• The role of the ubiquitin proteasome system in glioma: analysis emphasizing the main molecular players and therapeutic strategies identified in glioblastoma multiforme.

  2021cites this paper
• Ubiquitination of Nonhistone Proteins in Cancer Development and Treatment

  2021cites this paper
• PINK1-Mediated Inhibition of EGFR Dimerization and Activation Impedes EGFR-Driven Lung Tumorigenesis

  2021cites this paper
• Hidden phenotypes of PINK1/Parkin knockout mice.

  2021cites this paper
• The role of E3 ubiquitin ligases in the development and progression of glioblastoma

  2021influential citation
• Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases

  2021influential citation
• Analysis using top‐k skyline query of protein‐protein interaction reveals alpha‐synuclein as the most important protein in Parkinson’s disease

  2021cites this paper